全文获取类型
收费全文 | 14795篇 |
免费 | 848篇 |
国内免费 | 504篇 |
专业分类
系统科学 | 1495篇 |
丛书文集 | 324篇 |
教育与普及 | 241篇 |
理论与方法论 | 311篇 |
现状及发展 | 907篇 |
研究方法 | 22篇 |
综合类 | 12843篇 |
自然研究 | 4篇 |
出版年
2024年 | 17篇 |
2023年 | 55篇 |
2022年 | 108篇 |
2021年 | 128篇 |
2020年 | 99篇 |
2019年 | 46篇 |
2018年 | 785篇 |
2017年 | 834篇 |
2016年 | 543篇 |
2015年 | 295篇 |
2014年 | 338篇 |
2013年 | 420篇 |
2012年 | 701篇 |
2011年 | 1498篇 |
2010年 | 1322篇 |
2009年 | 1041篇 |
2008年 | 1186篇 |
2007年 | 1428篇 |
2006年 | 533篇 |
2005年 | 556篇 |
2004年 | 552篇 |
2003年 | 477篇 |
2002年 | 465篇 |
2001年 | 456篇 |
2000年 | 308篇 |
1999年 | 339篇 |
1998年 | 218篇 |
1997年 | 243篇 |
1996年 | 198篇 |
1995年 | 184篇 |
1994年 | 178篇 |
1993年 | 123篇 |
1992年 | 105篇 |
1991年 | 84篇 |
1990年 | 89篇 |
1989年 | 82篇 |
1988年 | 58篇 |
1987年 | 29篇 |
1986年 | 12篇 |
1985年 | 6篇 |
1984年 | 5篇 |
1980年 | 2篇 |
1967年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Salamah M. Alwahsh Hassan Rashidi David C. Hay 《Cellular and molecular life sciences : CMLS》2018,75(8):1307-1324
The prevalence of liver diseases is increasing globally. Orthotopic liver transplantation is widely used to treat liver disease upon organ failure. The complexity of this procedure and finite numbers of healthy organ donors have prompted research into alternative therapeutic options to treat liver disease. This includes the transplantation of liver cells to promote regeneration. While successful, the routine supply of good quality human liver cells is limited. Therefore, renewable and scalable sources of these cells are sought. Liver progenitor and pluripotent stem cells offer potential cell sources that could be used clinically. This review discusses recent approaches in liver cell transplantation and requirements to improve the process, with the ultimate goal being efficient organ regeneration. We also discuss the potential off-target effects of cell-based therapies, and the advantages and drawbacks of current pre-clinical animal models used to study organ senescence, repopulation and regeneration. 相似文献
992.
Margherita Ratti Andrea Lampis Jens C. Hahne Rodolfo Passalacqua Nicola Valeri 《Cellular and molecular life sciences : CMLS》2018,75(22):4151-4162
Gastric cancer is one of the most aggressive malignancies, with limited treatment options in both locally advanced and metastatic setting, resulting in poor prognosis. Based on genomic characterization, stomach tumour has recently been described as a heterogeneous disease composed by different subtypes, each of them with peculiar molecular aspects and specific clinical behaviour. With an incidence of 22% among all western gastric tumour cases, stomach cancer with microsatellite instability was identified as one of these subgroups. Retrospective studies and limited prospective trials reported differences between gastric cancers with microsatellite stability and those with instability, mainly concerning clinical and pathological features, but also in regard to immunological microenvironment, correlation with prognostic value, and responses to treatment. In particular, gastric cancer with microsatellite instability constitutes a small but relevant subgroup associated with older age, female sex, distal stomach location, and lower number of lymph-node metastases. Emerging data attribute to microsatellite instability status a favourable prognostic meaning, whereas the poor outcomes reported after perioperative chemotherapy administration suggest a detrimental role of cytotoxic drugs in this gastric cancer subgroup. The strong immunogenicity and the widespread expression of immune-checkpoint ligands make microsatellite instability subtype more vulnerable to immunotherapeutic approach, e.g., with anti-PD-L1 and anti-CTLA4 antibodies. Since gastric cancer with microsatellite instability shows specific features and clinical behaviour not overlapping with microsatellite stable disease, microsatellite instability test might be suitable for inclusion in a diagnostic setting for all tumour stages to guarantee the most targeted and effective treatment to every patient. 相似文献
993.
994.
Sei Yoshida Regina Pacitto Ken Inoki Joel Swanson 《Cellular and molecular life sciences : CMLS》2018,75(7):1227-1239
The growth and proliferation of metazoan cells are driven by cellular nutrient status and by extracellular growth factors. Growth factor receptors on cell surfaces initiate biochemical signals that increase anabolic metabolism and macropinocytosis, an actin-dependent endocytic process in which relatively large volumes of extracellular solutes and nutrients are internalized and delivered efficiently into lysosomes. Macropinocytosis is prominent in many kinds of cancer cells, and supports the growth of cells transformed by oncogenic K-Ras. Growth factor receptor signaling and the overall metabolic status of the cell are coordinated in the cytoplasm by the mechanistic target-of-rapamycin complex-1 (mTORC1), which positively regulates protein synthesis and negatively regulates molecular salvage pathways such as autophagy. mTORC1 is activated by two distinct Ras-related small GTPases, Rag and Rheb, which associate with lysosomal membranes inside the cell. Rag recruits mTORC1 to the lysosomal surface where Rheb directly binds to and activates mTORC1. Rag is activated by both lysosomal luminal and cytosolic amino acids; Rheb activation requires phosphoinositide 3-kinase, Akt, and the tuberous sclerosis complex-1/2. Signals for activation of Rag and Rheb converge at the lysosomal membrane, and several lines of evidence support the idea that growth factor-dependent endocytosis facilitates amino acid transfer into the lysosome leading to the activation of Rag. This review summarizes evidence that growth factor-stimulated macropinocytosis is essential for amino acid-dependent activation of mTORC1, and that increased solute accumulation by macropinocytosis in transformed cells supports unchecked cell growth. 相似文献
995.
996.
谐波检测是谐波问题的一个重要分支,对能够准确、实时地对电力系统谐波进行检测有着重要的意义.本文介绍了一种基于快速傅里叶的谐波检测方法,并应用其原理设计了一种基于DSP和AVR的新型谐波检测装置,该装置可完成国标规定的电能质量指标的测量,并有数据显示、存储和通信等功能.工程实际测量结果验证了该方案的可行性和可靠性.
关 相似文献
997.
目的探讨重症急性胰腺炎患者外周血单个核细胞线粒体DNA拷贝数与患者病情严重程度、预后的相关性。方法分离研究对象(重症急性胰腺炎患者34名,健康对照组17名)外周血单个核细胞,采用荧光实时定量PCR检测各组PBMC线粒体DNA相对舍量,其与严重程度、预后的相关性。结果重症急性胰腺炎患者线粒体DNA含量较健康对照组明显降低(P〈0.05)。患者单个核细胞线粒体DNA拷贝教与APACHEⅡ评分呈负相关(r=-0.425)其中并发症组mtDNA拷贝数显著低于无并发症组(P〈0.05)。结论重症急性胰腺炎患者外周血单个核细胞中线粒体DNA含量显著下降,与患者APACHEⅡ评分呈负相关,且低水平的线粒体DNA拷贝数提示并发症发生率的升高,因此,线粒体DNA拷贝数可作为潜在评估患者病情危重程度及预后的指标,这一发现值得进一步大型,前瞻性的研究。 相似文献
998.
Steinbusch LK Schwenk RW Ouwens DM Diamant M Glatz JF Luiken JJ 《Cellular and molecular life sciences : CMLS》2011,68(15):2525-2538
Cardiomyocytes use glucose as well as fatty acids for ATP production. These substrates are transported into the cell by glucose
transporter 4 (GLUT4) and the fatty acid transporter CD36. Besides being located at the sarcolemma, GLUT4 and CD36 are stored
in intracellular compartments. Raised plasma insulin concentrations and increased cardiac work will stimulate GLUT4 as well
as CD36 to translocate to the sarcolemma. As so far studied, signaling pathways that regulate GLUT4 translocation similarly
affect CD36 translocation. During the development of insulin resistance and type 2 diabetes, CD36 becomes permanently localized
at the sarcolemma, whereas GLUT4 internalizes. This juxtaposed positioning of GLUT4 and CD36 is important for aberrant substrate
uptake in the diabetic heart: chronically increased fatty acid uptake at the expense of glucose. To explain the differences
in subcellular localization of GLUT4 and CD36 in type 2 diabetes, recent research has focused on the role of proteins involved
in trafficking of cargo between subcellular compartments. Several of these proteins appear to be similarly involved in both
GLUT4 and CD36 translocation. Others, however, have different roles in either GLUT4 or CD36 translocation. These trafficking
components, which are differently involved in GLUT4 or CD36 translocation, may be considered novel targets for the development
of therapies to restore the imbalanced substrate utilization that occurs in obesity, insulin resistance and diabetic cardiomyopathy. 相似文献
999.
1000.
Gires O 《Cellular and molecular life sciences : CMLS》2011,68(24):4009-4022
Tumor-initiating cells (TICs) have emerged as the driving force of carcinomas, which appear as hierarchically structured.
TICs as opposed to the tumor bulk display tumor forming potential, which is linked to a certain degree of self-renewal and
differentiation, both major features of stem cells. Markers such as CD44, CD133, CD24, EpCAM, CD166, Lgr5, CD47, and ALDH
have been described, which allow for the prospective enrichment of TICs. It is conspicuous that the same markers allow for
an enrichment of TICs in various entities and, on the other hand, that different combinations of these markers were independently
reported for the same tumor entity. Potential functions of these markers in the regulation of TIC phenotypes remained somewhat
neglected although they might give insights in common molecular themes of TICs. The present review discusses major TIC markers
with respect to their function and potential contributions to the tumorigenic phenotype of TICs. 相似文献